コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 saccharide-neutralizing protein, also has an antiangiogenic effect.
2 VEGF-A signaling, whereas IFNgamma shows an antiangiogenic effect.
3 ance MHC class I presentation and exhibit an antiangiogenic effect.
4 mpair periodontal tissue repair, despite its antiangiogenic effect.
5 doses of type I IFNs occurs through a direct antiangiogenic effect.
6 horioallantoic membrane assay, suggesting an antiangiogenic effect.
7 The Y2R antagonist also exerted an antiangiogenic effect.
8 ivity in vivo, presumably as a result of its antiangiogenic effect.
9 ty of indications have been shown to exhibit antiangiogenic effects.
10 ma agent that has both antiproliferative and antiangiogenic effects.
11 ctivated endothelial cells leading to potent antiangiogenic effects.
12 1, which encodes a proteinase inhibitor with antiangiogenic effects.
13 tion of specific antimitotic and nonspecific antiangiogenic effects.
14 fic and as a result can yield either pro- or antiangiogenic effects.
15 nt pathways, through which IMiDs exert their antiangiogenic effects.
16 ombospondin-1, reinforcing its antitumor and antiangiogenic effects.
17 proteolytic fragments of these hormones have antiangiogenic effects.
18 clinical trials partly based on their potent antiangiogenic effects.
19 ults indicate a role for CD8+ T cells in the antiangiogenic effects.
20 nhances Th1-type T-cell responses and exerts antiangiogenic effects.
21 is and present a molecular mechanism for its antiangiogenic effects.
22 ceeded concentrations necessary for in vitro antiangiogenic effects.
23 h and metastasis by both direct and indirect antiangiogenic effects.
24 well tolerated in children, with evidence of antiangiogenic effect and potential clinical benefit in
25 CR-CSC-based mouse avatars, BMP7v exerts an antiangiogenic effect and sensitizes tumor cells to stan
26 growth factor receptor-beta (PDGFR-beta) for antiangiogenic effects and also inhibit human thymidylat
27 IFN-gamma and the Fas/FasL pathway in early antiangiogenic effects and in antitumor responses sugges
29 synthase on the cell surface may mediate its antiangiogenic effects and the down-regulation of endoth
30 ith this, alpha1(IV)NC1 elicited significant antiangiogenic effects and tumor growth inhibition in vi
31 than antigen-specific tumor immunity (e.g., antiangiogenic effects) and that use of human IL-12 shou
32 autophagy, an antitumor immune response, an antiangiogenic effect, and a significant "bystander" ant
33 imizing efficacy of chemotherapeutic agents, antiangiogenic effects, and altering antitumor immunity.
35 effects were most probably mediated via its antiangiogenic effects because TSP-1 did not affect the
36 a dominant-negative sKDR results in a strong antiangiogenic effect both on directly targeted cells an
37 ea catechins, possesses immunomodulatory and antiangiogenic effects, both of which contribute to its
38 enoside from ginseng root extract, possesses antiangiogenic effects, but its role on ocular cells has
39 in tumor cell lines, has been shown to have antiangiogenic effects, but the molecular mechanism of t
40 of this, we provide evidence that SEC exerts antiangiogenic effects by inhibiting branching microvess
42 teady-state MRI is highly sensitive to early antiangiogenic effects caused by small molecule drugs.
43 s benefit appears largely due to an enhanced antiangiogenic effect: Combination therapy reduced both
44 actor (TNF), can have both proangiogenic and antiangiogenic effects, depending on the dose and the pr
47 ort the hypothesis that TNF-alpha exerts its antiangiogenic effect in part by modulating the VEGF-spe
49 Neither angiostatin nor MAb3D5AB1 showed an antiangiogenic effect in the corneal neovascularization
50 noneutralization of HPX exerts a significant antiangiogenic effect in vitro and in retinal explants.
54 oxides 17,18-EEQ-EA and 19,20-EDP-EA exerted antiangiogenic effects in human microvascular endothelia
55 investigate their contribution to ( )-MRJF22 antiangiogenic effects in human retinal endothelial cell
57 This suggests that local CsA has negligible antiangiogenic effects in the human cornea, at least in
58 receptor kinase inhibitor SU5416, increased antiangiogenic effects in vitro and in a zebrafish angio
64 mycin in vivo, and provide evidence that its antiangiogenic effects may represent a downstream conseq
65 valuation of cell cycle, cell apoptosis, and antiangiogenic effects, molecular docking, and molecular
66 uggest that multikinase inhibitors may exert antiangiogenic effects not only by direct effects on end
67 of VEGF by bevacizumab explain the additive antiangiogenic effects observed in combination with Q8.
73 se results provide a molecular basis for the antiangiogenic effect of anthracycline therapy and have
74 giogenesis during therapy, despite a greater antiangiogenic effect of bevacizumab, such that a revers
75 study suggests that a major mechanism of the antiangiogenic effect of copper deficiency induced by TM
77 een lipid metabolism and angiogenesis and an antiangiogenic effect of HMG-CoA reductase inhibitors wi
79 essel formation in vivo, indicating that the antiangiogenic effect of IGFBP-3 is an IGF-independent p
82 ering with the C5aR1-CXCL4 axis reversed the antiangiogenic effect of platelets both in vitro and in
88 eased angiogenesis in MM bone marrow and the antiangiogenic effect of Thal formed the empiric basis f
89 xperimental toxic neuropathy results from an antiangiogenic effect of these drugs, resulting in destr
96 ion in C57BL/6 mice was used to evaluate the antiangiogenic effects of 2-ME and other microtubule inh
99 , therefore, delineate the mechanisms of the antiangiogenic effects of bortezomib on multiple myeloma
101 e, as verified by the simulation of both the antiangiogenic effects of cabozantinib and the antiresor
103 factor) could play a role in decreasing the antiangiogenic effects of docetaxel, whereas agents such
105 e anti-breast tumor effects of G129R and the antiangiogenic effects of endostatin by creating a novel
106 ew recent studies on the antitumorigenic and antiangiogenic effects of exogenously administered 2-met
112 recently reported the anti-inflammatory and antiangiogenic effects of inhibiting the gene encoding a
114 ophagic survival response can potentiate the antiangiogenic effects of Kringle 5 in endothelial cells
120 totic, antiproliferative, antimigratory, and antiangiogenic effects of this commercial CRP preparatio
121 is and associated tumor growth, and that the antiangiogenic effects of TIMP-3 appear to be mediated t
122 epleting intracerebral copper, also exhibits antiangiogenic effects on brain tumor growth in mice.
126 c-pharmacodynamic models mainly focus on the antiangiogenic effects on tumor growth but do not provid
127 anti-MM activity of PTK787, coupled with its antiangiogenic effects, provides the framework for clini
128 in tumor cells themselves could block these antiangiogenic effects, showing the complexity of the JA
130 t multiple myeloma (MM) because of its known antiangiogenic effects, the mechanism of its anti-MM act
131 nhibitor (FTI) exhibit antiproliferative and antiangiogenic effects through a mechanism that is poorl
135 ns of octreotide and NISAs are necessary for antiangiogenic effects, whereas nanomolar concentrations
136 ceptor pathways results in at least additive antiangiogenic effects, which may have implications for